The Globostad study OBS15990 eDiary App has been developed for the Prospective Observational Study of adult patients receiving Dupixent for atopic dermatitis.The App will collect eDiary information for subjects registered into this study.*Note: this App requires an activation code and can only be accessed by subjects who are participating in the OBS15990 trial